Global Biosurgery Market Report and Forecast 2024-2032

Global Biosurgery Market Outlook

The global biosurgery market size attained a value of USD 15.44 billion in 2023, driven by the rising use of biosurgery products to prevent excessive blood loss during surgeries and improve efficiency. The market is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032 to attain a value of USD 28.86 billion by 2032.

Rising Preference for Biosurgeries is Augmenting the Market Growth

The global market for biosurgery is being driven by the flourishing healthcare sector around the world. Owing to different factors such as old age, accidents, musculoskeletal disorders, among others, surgical procedures are augmenting the demand for biosurgery products, thereby invigorating the market growth. Biosurgery aids in preventing excessive blood loss during surgeries, thus preventing fatalities during the surgical procedure, thereby incrementing the efficiency of the surgeons.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Moreover, several technological advancements, including the development of plasma-based, multifunctional and multi-use products for biosurgeries are accelerating the market growth. In addition to this, biosurgery products that favour accelerated healing and reduction in post-op recovery are additional factors influencing the growth of the market.

Biosurgery: Market Segmentation

Biosurgery refers to a medical procedure involving the use of sterile maggots to treat patients with infected wounds, primarily in cases when the infection is resistant to traditional antibiotic treatment.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of product, the market can be divided into:

• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Haemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement

Based on application, the market can be categorised into:

• Orthopaedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynaecological Surgery
• Others

The EMR report looks into the regional markets of biosurgery like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Advancements in Healthcare Structure to Boost the Market growth of Biosurgery

The market growth of biosurgery can be attributed to advancements in the field of surgeries in the recent years. The introduction of surgical robots has led to a surge in the number of surgeries as robotic surgery minimises human contact and is driven on advanced computing technologies, which reduces the risk of error. Thus, these advancements are pushing the demand for biosurgery products and positively influencing the market growth. Furthermore, the rising adoption of biosurgeries for effective blood loss management through minimally invasive haemostatic agents and surgical sealants instead of conventional staples and sutures is another factor providing impetus to the market. In addition to this, the market growth can further be associated with robust investments into the healthcare structure and various research and development (R&D) activities.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global Biosurgery Market

The report presents a detailed analysis of the following key players in the global biosurgery market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Baxter International Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Johnson and Johnson Services, Inc.
• CryoLife Inc.
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report